BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 2369682)

  • 1. The median daily increment of leukocytes during hematopoietic recovery reflects the myeloid progenitor cell yield during leukapheresis in children.
    Emminger W; Emminger-Schmidmeier W; Höcker P; Gerhartl C; Kundi M; Gadner H
    Bone Marrow Transplant; 1990 Jun; 5(6):419-24. PubMed ID: 2369682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The median rise of leucocytes predicts the optimal days for leukapheresis in children.
    Emminger W; Emminger-Schmidmeier W; Höcker P; Kundi M; Peters C; Gadner H
    Bone Marrow Transplant; 1990 Jan; 5 Suppl 1():28-9. PubMed ID: 1969304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimizing the CD34+ and CD34+Thy-1+ stem cell content of peripheral blood collections.
    Stewart AK; Imrie K; Keating A; Anania S; Nayar R; Sutherland DR
    Exp Hematol; 1995 Dec; 23(14):1619-27. PubMed ID: 8542956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful autografting following myeloablative conditioning therapy with blood stem cells mobilized by chemotherapy plus rhG-CSF.
    Hohaus S; Goldschmidt H; Ehrhardt R; Haas R
    Exp Hematol; 1993 Apr; 21(4):508-14. PubMed ID: 7681782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral blood progenitor cell collections in cancer patients: analysis of factors affecting the yields.
    Sautois B; Fraipont V; Baudoux E; Fassotte MF; Hermanne JP; Jérusalem G; Bours V; Bosquée L; Schaaf-Lafontaine N; Paulus JM; Sondag D; Fillet G; Beguin Y
    Haematologica; 1999 Apr; 84(4):342-9. PubMed ID: 10190949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Large-volume leukapheresis in pediatric patients: pre-apheresis peripheral blood CD34+ cell count predicts progenitor cell yield.
    Díaz MA; Garcia-Sanchez F; Lillo R; Vicent MG; Vicario JL; Madero L
    Haematologica; 1999 Jan; 84(1):32-5. PubMed ID: 10091391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors affecting hemopoietic recovery after high-dose therapy and autologous peripheral blood progenitor cell transplantation: a single center experience.
    Olivieri A; Offidani M; Montanari M; Ciniero L; Cantori I; Ombrosi L; Masia CM; Centurioni R; Mancini S; Brunori M; Leoni P
    Haematologica; 1998 Apr; 83(4):329-37. PubMed ID: 9592983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of progenitor cell dose and preleukapheresis use of human recombinant granulocyte colony-stimulating factor on the recovery of hematopoiesis after blood stem cell autografting in children.
    Kawano Y; Takaue Y; Watanabe T; Saito S; Abe T; Hirao A; Sato J; Ninomiya T; Suzue T; Koyama T
    Exp Hematol; 1993 Jan; 21(1):103-8. PubMed ID: 7678082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Characteristics of autologous peripheral blood stem cells in pediatric patients].
    Bojanić I; Golubić Cepulić B; Nemet D; Rajić L; Batinić D; Labar B
    Lijec Vjesn; 2006; 128(1-2):43-8. PubMed ID: 16640227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood progenitor cell (BPC) mobilization studied in multiple myeloma, solid tumor and non-Hodgkin's lymphoma patients after combination chemotherapy and G-CSF.
    Engelhardt M; Winkler J; Waller C; Lange W; Mertelsmann R; Henschler R
    Bone Marrow Transplant; 1997 Mar; 19(6):529-37. PubMed ID: 9181898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitation of primitive and lineage-committed progenitors in mobilized peripheral blood for prediction of platelet recovery post autologous transplant.
    Hogge DE; Lambie K; Sutherland HJ; Benny WB; Dalal B; Currie C; Barnett MJ; Eaves AC; Eaves CJ
    Bone Marrow Transplant; 2000 Mar; 25(6):589-98. PubMed ID: 10734292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Autologous peripheral stem cell transplantation in children].
    Emminger W; Emminger-Schmidmeier W; Höcker P; Hawliczek R; Peters C; Pawlowsky J; Neuwirth G; Kummer M; Gadner H
    Klin Padiatr; 1989; 201(4):299-303. PubMed ID: 2570882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Large-volume leukapheresis for peripheral blood progenitor cell collection in low body weight pediatric patients: a single center experience.
    Cecyn KZ; Seber A; Ginani VC; Gonçalves AV; Caram EM; Oguro T; Oliveira OM; Carvalho MM; Bordin JO
    Transfus Apher Sci; 2005 Jun; 32(3):269-74. PubMed ID: 15908275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with granulocyte colony-stimulating factor-induced peripheral blood stem cell yield in healthy donors.
    Suzuya H; Watanabe T; Nakagawa R; Watanabe H; Okamoto Y; Onishi T; Abe T; Kawano Y; Kagami S; Takaue Y
    Vox Sang; 2005 Nov; 89(4):229-35. PubMed ID: 16262756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Very large amounts of peripheral blood progenitor cells eliminate severe thrombocytopenia after high-dose melphalan in advanced breast cancer patients.
    Benedetti G; Patoia L; Giglietti A; Alessio M; Pelicci P; Grignani F
    Bone Marrow Transplant; 1999 Nov; 24(9):971-9. PubMed ID: 10556956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A nylon wool filter coated with human immunoglobulin for rapid depletion of monocytes and myeloid cells from peripheral blood stem cell transplants.
    Kwekkeboom J; Buurman DE; Ploemacher RE; Baars JW; Loos HA; Slaper-Cortenbach IC
    Exp Hematol; 1998 May; 26(5):400-8. PubMed ID: 9590656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stem cell mobilization with G-CSF alone in breast cancer patients: higher progenitor cell yield by delivering divided doses (2 x 5 microg/kg) compared to a single dose (1 x 10 microg/kg).
    Kröger N; Zeller W; Hassan HT; Krüger W; Gutensohn K; Löliger C; Zander AR
    Bone Marrow Transplant; 1999 Jan; 23(2):125-9. PubMed ID: 10197796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autologous transplantation of chemotherapy-purged PBSC collections from high-risk leukemia patients: a pilot study.
    Lemoli RM; Visani G; Leopardi G; Motta MR; Rizzi S; Testoni N; Curti A; Tura S
    Bone Marrow Transplant; 1999 Feb; 23(3):235-41. PubMed ID: 10084254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant human granulocyte and granulocyte-macrophage colony-stimulating factor (G-CSF and GM-CSF) administered following cytotoxic chemotherapy have a similar ability to mobilize peripheral blood stem cells.
    Hohaus S; Martin H; Wassmann B; Egerer G; Haus U; Färber L; Burger KJ; Goldschmidt H; Hoelzer D; Haas R
    Bone Marrow Transplant; 1998 Oct; 22(7):625-30. PubMed ID: 9818688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose granulocyte colony-stimulating factor enables the efficient collection of peripheral blood stem cells after disease-oriented, conventional-dose chemotherapy for breast cancer, malignant lymphoma and germ cell tumor.
    Kohno A; Takeyama K; Narabayashi M; Okamoto R; Adachi I; Tobinai K; Shimoyama M
    Bone Marrow Transplant; 1995 Jan; 15(1):49-54. PubMed ID: 7538002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.